fmoc-l-b-Homoisoleucine, 95.0%, 250mg

1-(4-Cyanophenyl)-N,N-dimethylmethanesulfonamide, 97%, 250mg

2,2'-[iminobis(ethane-2,1-diyl)]bis(1H-isoindole-1,3(2H)-dione), 95%, 2g

1,2-Dibromo-3,5-difluorobenzene, 99.0%, 100g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 97.0%, 5g

Glycocholic acid (sodium), 100g

4-Chloro-3,5-dibromo-tert-butylbenzene, 95.0%, 5g

BILASTINE, 95%, 100mg

4,2'-Dimethoxybenzophenone, 98.0%, 1g

4-(Methylsulfonyl)-2-morpholinobenzoic acid, 95.0%, 5g

2-Amino-4-(4-pyridyl)thiazole, 97.0%, 5g

Essence 135-180, pure, 2,5 l, emballage en verre

tert-Butyl 4-(4-Bromo-1H-pyrazol-1-yl)piperidine-1-carboxylate, 97.0%, 1g